Inhibition of tumour necrosis factor production in endotoxin-stimulated human mononuclear leukocytes by the prostacyclin analogue iloprost: Cellular mechanisms

Cytokine

Volumn 9, Issue 2, 1997, Pages 119-125

  Jörres, Achim ^c   Dinter, Harald ^a   Topley, Nicholas ^b   Gahl, Gerhard M ^c   Frei, Ulrich ^c   Scholz, Peter ^a  

^a BAYER PHARMA AG   (Germany)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Endotoxin; Iloprost; TNF inhibition; Tumour necrosis factor alpha

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; DACTINOMYCIN; ENDOTOXIN; ILOPROST; MESSENGER RNA; PROSTACYCLIN; TUMOR NECROSIS FACTOR;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; ENZYME IMMUNOASSAY; ESCHERICHIA COLI; HUMAN; HUMAN CELL; MOLECULAR STABILITY; MONOCYTE; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN SECRETION; TRANSCRIPTION REGULATION;

EID: 0031081561     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1006/cyto.1996.0145     Document Type: Article

References (28)

1. 1. Tracey KJ, Beutler B, Lowry SF, Merryweather J, Wolpe S, Milsark IW, Hariri RJ, Fahey TJ, Zentella A, Albert JD, et al. (1986) Shock and tissue injury induced by recombinant human cachectin. Science 234:470-474.
2. 2. Silva AT, Bayston KF, Cohen J (1990) Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-alpha in experimental gram-negative shock. J Infect Dis 162:421-427.
3. 3. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, George CK, Lowry SF, Cerami A (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteriaemia. Nature 330:662-664.
4. 4. Walsh CJ, Sugerman HJ, Mullen PG, Carey PD, Leeper Woodford SK, Jesmok GJ, Ellis EF, Fowler AA (1992) Monoclonal antibody to tumor necrosis factor alpha attenuates cardiopulmonary dysfunction in porcine gram-negative sepsis. Arch Surg 127:138-144.
5. 5. Emerson TE, Jr., Lindsey DC, Jesmok GJ, Duerr ML, Fournel MA (1992) Efficacy of monoclonal antibody against tumor necrosis factor alpha in an endotoxemic baboon model. Circ Shock 38:75-84.
6. 6. Haak Frendscho M, Marsters SA, Mordenti J, Brady S, Gillett NA, Chen SA, Ashkenazi A (1994) Inhibition of TNF by a TNF receptor immunoadhesin. Comparison to an anti-TNF monoclonal antibody. J Immunol 152:1347-1353.
7. 7. Ashkenazi A, Marsters SA, Capon DJ, Chamow SM, Figari IS, Pennica D, Goeddel DV, Palladino MA, Smith DH (1991) Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin. Proc Natl Acad Sci USA 88:10535-10539.
8. 8. Lechner AJ, Rouben LR, Potthoff LH, Tredway TL, Matuschak GM (1993) Effects of pentoxifylline on tumor necrosis factor production and survival during lethal E. coli sepsis vs. disseminated candidiasis with fungal septic shock. Circ Shock 39:306-315.
9. 9. Zabel P, Schade FU, Schlaak M (1993) Inhibition of endogenous TNF formation by pentoxifylline. Immunobiology 187:447-463.
10. 10. Endres S, Fulle HJ, Sinha B, Stoll D, Dinarello CA, Gerzer R, Weber PC (1991) Cyclic nucleotides differentially regulate the synthesis of tumour necrosis factor-alpha and interleukin-1 beta by human mononuclear cells. Immunology 72:56-60.
11. 11. Noel P, Nelson S, Bokulic R, Bagby G, Lippton H, Lipscomb G, Summer W (1990) Pentoxifylline inhibits lipopolysaccharide-induced serum tumor necrosis factor and mortality. Life Sci 47:1023-1029.
12. 12. Kunkel SL, Wiggins RC, Chensue SW, Larrick J (1986) Regulation of macrophage tumor necrosis factor production by prostaglandin E2. Biochem Biophys Res Commun 137:404-410.
13. 2 regulates macrophage-derived tumor necrosis factor gene expression. J Biol Chem 263:5380-5384.
14. 14. Knudsen PJ, Dinarello CA, Strom TB (1988) Prostaglandins post-transcriptionally inhibit monocyte expression of interleukin-1 activity by increasing intracellular cAMP. J Immunol 137:3189-3194.
15. 15. Grundmann HJ, Hähnle U, Hegenscheid B, Sahlmuller G, Bienzle U, Blitstein-Willinger E (1992) Inhibition of endotoxin-induced macrophage tumor necrosis factor expression by a prostacyclin analogue and its beneficial effect in experimental lipopolysaccharide intoxication. J Infect Dis 165:501-505.
16. 16. Jörres A, Luttmann W, Scholz P, Thierauch K-H, Gahl GM, Topley N, Frei U, Blitstein-Willinger E (1994) Specific inhibition of tumour necrosis factor in endotoxin-stimulated mononuclear leukocytes by the prostacyclin analogue iloprost. Clin Intensive Care 5:296-302.
17. 17. Hildebrand M, Krause W, Oberender HA, Zurdel-Dillinger S, Jünger M, Bodenburg H (1990) Pharmacokinetics of iloprost in patients with severe peripheral arterial occlusive disease. Eicosanoids 3:145-148.
18. 18. Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A (1986) Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232:977-980.
19. 19. Han J, Brown T, Beutler B (1990) Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J Exp Med 171:465-475.
20. 20. Shaw G, Kamen R (1986) A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659-667.
21. 21. Caput D, Beutler B, Hartog K, Thayer R, Brown Shimer S, Cerami A (1986) Identification of a common nucleotide sequence in the 3′-untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sci USA 83:1670-1674.
22. 22. Beutler B, Thompson P, Keyes J, Hagerty K, Crawford D (1988) Assay of a ribonuclease that preferentially hydrolyses mRNAs containing cytokine-derived UA-rich instability sequences. Biochem Biophys Res Commun 152:973-980.
23. 23. Beutler B, Cerami A (1989) The biology of cachectin/TNF-a primary mediator of the host response. Annu Rev Immunol 7:625-655.
24. 23. Ashby B (1992) Comparison of Iloprost, Cicaprost and prostacyclin effects on cyclic AMP metabolism in intact platelets. Prostaglandins 43:255-261.
25. 24. Jörres A, Topley N, Steenweg L, Müller C, Köttgen E, Gahl GM (1992) Inhibition of cytokine synthesis by peritoneal dialysate persists throughout the CAPD cycle. Am J Nephrol 12:80-85.
26. 25. Wang AM, Creasey AA, Ladner MB, Lin LS, Strickler J, Van Arsdell JN, Yamamoto R, Mark DF (1985) Molecular cloning of the complementary DNA for human tumor necrosis factor. Science 228:149-154.
27. 26. O'Bryan JP, Frye RA, Cogswell PC, Neubauer A, Kitch B, Prokop C, Espinosa R3, Le Beau MM, Earp HS, Liu ET (1991) axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase. Mol Cell Biol 11:5016-5031.
28. 28. Haendler B, Hofer Warbinek R, Hofer E (1987) Complementary DNA for human T-cell cyclophilin. EMBO J 6:947-950.